Abstract Submission

Important Dates

The abstract submission period is from Thursday, January 15 to Tuesday, March 31, 2026 (JST).
Notification of acceptance/rejection: mid-June 2026

Presentation Styles and Topics

Accepted abstracts will be presented in Oral Sessions or Poster Sessions.
All presentations must be in English.
Authors can indicate their choice of preferred type of presentation in our submission system.

Abstract Categories

Authors will be asked to select one topic from the list below.

Presentation Formats

• Accepted abstracts will be presented in Oral Sessions or Poster Sessions.
• The format (oral/poster) will be determined by the Local Organizing Committee following careful peer review.
• All presentations must be in English.

Guidelines for Abstract Submission

• Abstracts must be written in English.
• Length requirements:

  -

  Abstract title: maximum of 25 words

  -

  Abstract text: maximum of 250 words

• COI disclosure is required
• Encore abstracts will be accepted.

Abstract title

All abstract titles must be written in sentence case. Do not include a period at the end of the title or use underlining.

Abstract text

Abstracts should be organized containing Background, Methods, Results, and Conclusion.

A)

Background:
State the purpose of the study (preferably in one sentence.)

B)

Methods:
Briefly describe the methods used. For clinical research, include key eligibility criteria for participants.

C)

Results:
Summarize the results with sufficient detail, including statistical analysis where appropriate.

D)

Conclusion:
State the conclusions clearly. Statements such as “results will be discussed” or “data will be presented” are not acceptable.

E)

Others:
Tables, graphs and references should not be included in the abstract.

Please note:
Abstracts must be proofread carefully to avoid errors before submission.

Affiliations

Affiliations should be indicated in the following manner.

Example:

-

Department of Pediatrics, AAA University

-

Department of Dermatology, BBB Hospital

-

R & D Department, CCC Corporation

• If an abstract does not conform to these guidelines, the Local Organizing Committee may modify it to align with the style of the Japanese Journal of Allergology.
• Tables and graphs should not be included in the abstract.
• References can be included in the body of the text.

Conflict-of-Interest Disclosure Policy

Please download the following file to find the details of COI declaration below.

Download

Notification of Acceptance

Notification of acceptance or rejection will be sent via email by mid-June2026. All correspondence including acceptance/rejection of abstracts, presentation format, date and time of presentation will be informed via email to the email address provided in the abstract submission form.

Abstract Withdrawal

Please notify Secretariat via email at endai-jsajoint2026[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . ) by July 31, 2026 stating the title and number of the abstract to be withdrawn.

Publication of Abstracts

Accepted abstracts will be published in the Japanese Journal of Allergology.

Attendance of Presenters

All accepted abstracts that are not withdrawn before July 31, 2026 must be presented by the author or a designated representative. No-shows may jeopardize submission of future abstracts by the same individuals or institutions.

Format of the Meeting

Speakers are required to attend and present onsite at the Kyoto International Conference Center.

Travel Grants

We welcome participants from around the world. To encourage early-career researchers to travel to Kyoto, the Joint Congress 2026 will offer a limited number of Travel Grants to students and postdoctoral/clinical fellow presenters whose abstracts have been accepted.

Grant Amounts (by region)

Asia–Oceania (100,000 JPY)	10 recipients
North America (200,000 JPY)	5 recipients
Europe (200,000 JPY)	5 recipients
South America (300,000 JPY)	3 recipients
Middle East & Africa (300,000 JPY)	3 recipients

Eligibility

-

Working in the field of allergy or clinical immunology

-

Either under 35 years of age at the time of the congress (Oct 15,2026) or within 5 years of completing a training program in allergy, asthma, clinical immunology, or a related field

-

Currently working or training outside Japan

-

Not a Japanese national

-

Submitting an abstract to the Joint Congress 2026 as the presenting author during the official submission period, and having it accepted

-

Able to present the abstract on-site at the Joint Congress 2026

Notes

Abstracts and presentation materials must be prepared entirely in English.
Applicants are responsible for arranging and completing their own visa procedures, if required for entry into Japan.

Application

Application Deadline: March 31, 2026
Submit certification documents signed by your Training Director via the link below.

Upload: Certification Documents

Contact Information

For further information, please contact Secretariat at endai-jsajoint2026[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . ).
Secretariat of the JSA/WAO/APAPARI Joint Congress 2026
c/o Japan Convention Services Inc.